PHARMAESSENTIA CORP.
Area: Government, Academia and Research Institutes
Booth No: N604
Website: https://hq.pharmaessentia.com/tw
Exhibitor Profile
PharmaEssentia creates a novel product- Ropeginterferon alfa-2b, it’s a long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties allowing once every two weeks administration offering improved tolerability and convenience. The marketing authorization for Ropeginterferon alfa-2b for treatment of Polycythemia Vera (PV) is granted by EMA, Taiwan, Korea, US, Japan, Singapore, Malaysia, China and Brazil.
Brands
Ropeginterferon alfa-2b
Exhibit Products
Exhibitors you may be interested in
Highest Rated